HG-301

N/A

Report date: 2024/09/29 15:10:37

Base Information

Drug NameHG-301
Drug Alias NameHG-301HG301
ClassificationCell and gene therapy > Gene therapy > Gene editing > CRISPR > CRISPR-Cas12
Mechanisms of ActionRHO gene transference
TargetsRhodopsin
Therapy Area/IndicationsRetinitis Pigmentosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesHuidaGene Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHuidaGene Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsRetinitis Pigmentosa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A